Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2019, Article ID 7405602, 7 pages
https://doi.org/10.1155/2019/7405602
Research Article

CTRP3 Protects against High Glucose-Induced Cell Injury in Human Umbilical Vein Endothelial Cells

1Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Correspondence should be addressed to Ran Li; nc.ude.uzz@2rilccf and Guijun Qin; nc.ude.uzz@jgniqyh

Received 19 March 2019; Accepted 12 June 2019; Published 24 July 2019

Academic Editor: Silvia Cantara

Copyright © 2019 Fang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Dymkowska, B. Drabarek, P. Podszywalow-Bartnicka, J. Szczepanowska, and K. Zablocki, “Hyperglycaemia modifies energy metabolism and reactive oxygen species formation in endothelial cells in vitro,” Archives of Biochemistry and Biophysics, vol. 542, pp. 7–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Shenouda, M. E. Widlansky, K. Chen et al., “Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus,” Circulation, vol. 124, no. 4, pp. 444–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Taye, A. H. Saad, A. H. S. Kumar, and H. Morawietz, “Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose,” European Journal of Pharmacology, vol. 627, no. 1-3, pp. 42–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Siperstein, D. W. Foster, H. C. Knowles Jr., R. Levine, L. L. Madison, and J. Roth, “Control of blood glucose and diabetic vascular disease,” The New England Journal of Medicine, vol. 296, no. 18, pp. 1060–1063, 1977. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Fan, D. Han, Z. Sun et al., “Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammation,” Free Radical Biology & Medicine, vol. 108, pp. 725–740, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. Toque, A. Fernandez-Flores, R. Mohamed, R. B. Caldwell, G. Ramesh, and R. W. Caldwell, “Netrin-1 is a novel regulator of vascular endothelial function in diabetes,” PLoS One, vol. 12, no. 10, article e0186734, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Piga, Y. Naito, S. Kokura, O. Handa, and T. Yoshikawa, “Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells,” Atherosclerosis, vol. 193, no. 2, pp. 328–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Weigert, M. Neumeier, A. Schäffler et al., “The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells,” FEBS Letters, vol. 579, no. 25, pp. 5565–5570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. G. Ma, Y. P. Yuan, S. C. Xu et al., “CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats,” Diabetologia, vol. 60, no. 6, pp. 1126–1137, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Kishore, C. Gaboriaud, P. Waters et al., “C1q and tumor necrosis factor superfamily: modularity and versatility,” Trends in Immunology, vol. 25, no. 10, pp. 551–561, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. P. Yuan, Z. G. Ma, X. Zhang et al., “CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1,” Journal of Molecular and Cellular Cardiology, vol. 114, pp. 38–47, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Yi, Y. Sun, Y. Yuan et al., “C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart,” Circulation, vol. 125, no. 25, pp. 3159–3169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Y. Wei, Z. G. Ma, N. Zhang et al., “Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in mice,” Molecular and Cellular Endocrinology, vol. 476, pp. 27–36, 2018. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kopp, M. Bala, C. Buechler et al., “C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue,” Endocrinology, vol. 151, no. 11, pp. 5267–5278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. G. Ma, J. Dai, Y. P. Yuan et al., “T-bet deficiency attenuates cardiac remodelling in rats,” Basic Research in Cardiology, vol. 113, no. 3, p. 19, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. G. Ma, Y. P. Yuan, X. Zhang et al., “C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice,” Cardiovascular Research, vol. 115, no. 6, pp. 1067–1077, 2019. View at Publisher · View at Google Scholar
  17. D. Wu, H. Lei, J. Y. Wang et al., “CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation,” Journal of Molecular Medicine (Berlin, Germany), vol. 93, no. 12, pp. 1311–1325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mu, T. L. Yin, L. Yin, X. Hu, and J. Yang, “CTRP3 attenuates high-fat diet-induced male reproductive dysfunction in mice,” Clinical Science (London, England), vol. 132, no. 8, pp. 883–899, 2018. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Li, Y. Li, J. M. Overstreet et al., “Inhibition of epidermal growth factor receptor activation is associated with improved diabetic nephropathy and insulin resistance in type 2 diabetes,” Diabetes, vol. 67, no. 9, pp. 1847–1857, 2018. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Rao, L. B. V. Rao, S. H. Tan, M. Candasamy, and S. K. Bhattamisra, “Diabetic nephropathy: an update on pathogenesis and drug development,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 13, no. 1, pp. 754–762, 2019. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Sharma, P. Bhattacharya, K. Kalia, and V. Tiwari, “Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets,” Diabetes Research and Clinical Practice, vol. 128, pp. 91–108, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. G. H. Tesch, “MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy,” American Journal of Physiology. Renal Physiology, vol. 294, no. 4, pp. F697–F701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. P. Soares, A. Muniappan, E. Kaczmarek et al., “Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis,” Journal of Immunology, vol. 161, no. 9, pp. 4572–4582, 1998. View at Google Scholar
  24. Z. Zhang, M. Jiang, X. Xie et al., “Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via PPARδ activation,” Scientific Reports, vol. 7, no. 1, article 40237, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Li, Y. Xu, R. Guan et al., “Icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway,” Andrology, vol. 3, no. 2, pp. 408–416, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Downward, “Mechanisms and consequences of activation of protein kinase B/Akt,” Current Opinion in Cell Biology, vol. 10, no. 2, pp. 262–267, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Yamaguchi and H. G. Wang, “The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change,” Oncogene, vol. 20, no. 53, pp. 7779–7786, 2001. View at Publisher · View at Google Scholar · View at Scopus